It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Late-term fetal demise including fetal death in utero, late miscarriage and late termination of pregnancy are relatively frequent occurrences. Post-traumatic stress disorder (PTSD) is a pathology that finds its roots in exposure to a life-threatening event or an event related to death. Exposure to fetal death during a late-term fetal demise is, therefore, a situation at risk of trauma. The objective of this study was to assess the prevalence of PTSD symptoms in the short term among patients faced with late fetal demise, and to identify potential risk factors. All women were assessed at 15 days, one month, and three months after late fetal demise using the Impact of Event Scale-Revised (IES-R) and the Peritraumatic Dissociative Experiences Questionnaire (PDEQ). At 15 days, 44.2% of patients presented a pathological score on the IES-R (≥ 33). At one month and three months, this figure was 34.1% and 9.1% respectively. Factor associated with PTSD symptoms were: peritraumatic dissociation (p = 0.014), seeing the fetus during hospitalization (p = 0.035), holding the fetus in one’s arms (p = 0.046), and the organization of a funeral service (p = 0.025). Patients experiencing late fetal demise are at significant risk of trauma. Care providers should remain vigilant to identify high-risk situations to offer appropriate care.
Clinical trials registration number: NCT03433989.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Angers University Hospital, Department of Obstetrics and Gynecology, Angers, France (GRID:grid.411147.6) (ISNI:0000 0004 0472 0283); Paris-Sud University, Paris-Saclay University, Inserm, CESP-Inserm, U1018, Research in Ethics and Epistemology (R2E), Paris, France (GRID:grid.7429.8) (ISNI:0000000121866389)
2 Angers University Hospital, Department of Obstetrics and Gynecology, Angers, France (GRID:grid.411147.6) (ISNI:0000 0004 0472 0283); Paris-Sud University, Paris-Saclay University, UVSQ, Inserm, CESP-Inserm, U1018, Team 7, Genre, Sexual and Reproductive Health, Villejuif, France (GRID:grid.411147.6)
3 Angers University Hospital, Department of Obstetrics and Gynecology, Angers, France (GRID:grid.411147.6) (ISNI:0000 0004 0472 0283)
4 Angers University Hospital, Department of Clinical Research and Innovation, Angers, France (GRID:grid.411147.6) (ISNI:0000 0004 0472 0283)
5 Angers University Hospital, Department of Child Psychiatry, Angers, France (GRID:grid.411147.6) (ISNI:0000 0004 0472 0283)
6 Angers University Hospital, Department of Child Psychiatry, Angers, France (GRID:grid.411147.6) (ISNI:0000 0004 0472 0283); Angers University, Department of Psychology Laboratoire LPPLEA4638, Angers, France (GRID:grid.7252.2) (ISNI:0000 0001 2248 3363); Unité Micovasc, UMR CNRS 6015-INSERM, Angers, France (GRID:grid.7252.2)